Open Access

Erratum to: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

  • Xenofon Baraliakos1,
  • Joachim Listing2,
  • Jan Brandt1,
  • Angela Zink2,
  • Rieke Alten3,
  • Gerd Burmester4,
  • Erika Gromnica-Ihle5,
  • Herbert Kellner6,
  • Matthias Schneider7,
  • Helmut Sörensen8,
  • Hennig Zeidler9,
  • Martin Rudwaleit10,
  • Joachim Sieper10 and
  • Juergen Braun1Email author
Arthritis Research & Therapy20057:113

DOI: 10.1186/ar1750

Published: 23 March 2005

The original article was published in Arthritis Research & Therapy 2005 7:R439

After publication of this work [1], we noted that we inadvertently failed to include the complete list of all coauthors. The full list of authors has now been added and the Authors' contributions and Competing interests section modified accordingly.

Notes

Declarations

Authors’ Affiliations

(1)
Rheumazentrum Ruhrgebiet, Herne, Ruhr University Bochum
(2)
German Rheumatism Research Center
(3)
Schlosspark Clinic
(4)
Charité, University Medicine Berlin
(5)
Berlin-Buch Hospital
(6)
Ludwig-Maximilians-University
(7)
Heinrich-Heine-University
(8)
Private Praxis
(9)
Medical University of Hannover
(10)
Charité, Medical University of Berlin, Campus Benjamin Franklin, Department of Rheumatology

References

  1. Baraliakos X, Listing J, Brandt J, Rudwaleit M, Sieper , Braun J: Clinical response to withdrawal of anti-TNF therapy in patients with ankylosing spondylitis (AS) after 3 years of continuous treatment with Infliximab. Arthritis Res Ther. 2005, 7: R439-R444. 10.1186/ar1693.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© BioMed Central Ltd 2005

Advertisement